BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 26919103)

  • 21. CCN5 inhibits proliferation and promotes apoptosis of oral squamous cell carcinoma cells.
    Sun S; Cui Z; Yan T; Wu J; Liu Z
    Cell Biol Int; 2020 Apr; 44(4):998-1008. PubMed ID: 31889370
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Janus-faced roles of Krüppel-like factor 4 in oral squamous cell carcinoma cells.
    Li W; Liu M; Su Y; Zhou X; Liu Y; Zhang X
    Oncotarget; 2015 Dec; 6(42):44480-94. PubMed ID: 26517087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. THBS1 is induced by TGFB1 in the cancer stroma and promotes invasion of oral squamous cell carcinoma.
    Pal SK; Nguyen CT; Morita KI; Miki Y; Kayamori K; Yamaguchi A; Sakamoto K
    J Oral Pathol Med; 2016 Nov; 45(10):730-739. PubMed ID: 26850833
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Carboxylesterase 2 induces mitochondrial dysfunction via disrupting lipid homeostasis in oral squamous cell carcinoma.
    Chen X; Liu Q; Chen Y; Wang L; Yang R; Zhang W; Pan X; Zhang S; Chen C; Wu T; Xia J; Cheng B; Chen X; Ren X
    Mol Metab; 2022 Nov; 65():101600. PubMed ID: 36113774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein S drives oral squamous cell carcinoma tumorigenicity through regulation of AXL.
    Abboud-Jarrous G; Priya S; Maimon A; Fischman S; Cohen-Elisha M; Czerninski R; Burstyn-Cohen T
    Oncotarget; 2017 Feb; 8(8):13986-14002. PubMed ID: 28118606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased expression of lncRNA CASC9 promotes tumor progression by suppressing autophagy-mediated cell apoptosis via the AKT/mTOR pathway in oral squamous cell carcinoma.
    Yang Y; Chen D; Liu H; Yang K
    Cell Death Dis; 2019 Jan; 10(2):41. PubMed ID: 30674868
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxia induced Bcl-2/Twist1 complex promotes tumor cell invasion in oral squamous cell carcinoma.
    Duan Y; He Q; Yue K; Si H; Wang J; Zhou X; Wang X
    Oncotarget; 2017 Jan; 8(5):7729-7739. PubMed ID: 28032603
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Notch Signaling Activation Is Associated with Patient Mortality and Increased FGF1-Mediated Invasion in Squamous Cell Carcinoma of the Oral Cavity.
    Weaver AN; Burch MB; Cooper TS; Della Manna DL; Wei S; Ojesina AI; Rosenthal EL; Yang ES
    Mol Cancer Res; 2016 Sep; 14(9):883-91. PubMed ID: 27353029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paraoxonase 3 promotes cell proliferation and metastasis by PI3K/Akt in oral squamous cell carcinoma.
    Zhu L; Shen Y; Sun W
    Biomed Pharmacother; 2017 Jan; 85():712-717. PubMed ID: 27923688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Signal regulatory protein α associated with the progression of oral leukoplakia and oral squamous cell carcinoma regulates phenotype switch of macrophages.
    Ye X; Zhang J; Lu R; Zhou G
    Oncotarget; 2016 Dec; 7(49):81305-81321. PubMed ID: 27793032
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Muc-1 promotes migration and invasion of oral squamous cell carcinoma cells via PI3K-Akt signaling.
    Li P; Xiao LY; Tan H
    Int J Clin Exp Pathol; 2015; 8(9):10365-74. PubMed ID: 26617744
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Macrophage migration inhibitory factor is a novel prognostic marker for human oral squamous cell carcinoma.
    Kang Y; Zhang Y; Sun Y
    Pathol Res Pract; 2018 Aug; 214(8):1192-1198. PubMed ID: 30041958
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-21 promotes perineural invasion and impacts survival in patients with oral carcinoma.
    Yu EH; Tu HF; Wu CH; Yang CC; Chang KW
    J Chin Med Assoc; 2017 Jun; 80(6):383-388. PubMed ID: 28254348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP3 promotes tumor growth and metastasis in human oral squamous cell carcinoma.
    Wang H; Luo Q; Feng X; Zhang R; Li J; Chen F
    BMC Cancer; 2018 May; 18(1):500. PubMed ID: 29716544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DKK2 promotes the progression of oral squamous cell carcinoma through the PI3K/AKT signaling pathway.
    Guo W; Qu Y; Yu Y; Li X; Liang Z; Wang Z; Hu T; Zhou S
    Aging (Albany NY); 2024 May; 16(10):9204-9215. PubMed ID: 38795388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CC Chemokine Ligand 18 Promotes Cell Proliferation and Metastasis of Urothelial Carcinoma via Activating PI3K/mTOR Signaling in Patient with Renal Transplantation.
    Bo S; Donghao S; Guangqi K; Ye T
    Urol Int; 2018; 101(4):450-458. PubMed ID: 30189425
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spindle and kinetochore-associated complex 3 promotes cell growth via the PI3K/AKT/GSK3β and PI3K/AKT/FOXO1 pathways and is a potential prognostic biomarker for oral squamous cell carcinoma.
    Xu H; Chen G; Niu Q; Song K; Feng Z; Han Z
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2022 Nov; 134(5):599-614. PubMed ID: 36123287
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.